相关实验视频

Updated: Feb 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

在实用心血管试验中使用人工智能评估治疗效果异质性:来自TRANSFORM-HF的见解

Guangyu Tong, Changjun Li, Fan Li

    medRxiv : the preprint server for health sciences
    |February 6, 2026
    PubMed
    概括

    机器学习发现,托塞米德对没有心房动的心力衰竭患者有好处,而富罗塞米德对患有心房动的人来说更好. 这突出了个性化的利尿剂选择在心力衰竭治疗.

    更多相关视频

    Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention06:37

    Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

    Published on: December 15, 2023

    5.4K
    Artificial Intelligence Approaches to Assessing Primary Cilia08:58

    Artificial Intelligence Approaches to Assessing Primary Cilia

    Published on: May 1, 2021

    4.2K

    相关概念视频

    Assessment of the Cardiovascular System II: Inspection01:29

    Assessment of the Cardiovascular System II: Inspection

    Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
    Head and Neck
    878
    Assessment of the Cardiovascular System IV: Auscultation01:25

    Assessment of the Cardiovascular System IV: Auscultation

    Cardiac auscultation is a clinical skill used to assess heart function and detect abnormalities. It involves listening to heart sounds at specific anatomical locations through a stethoscope.
    Normal Heart Sounds
    S1 (First Heart Sound)-
    S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
    S2 (Second Heart Sound)-
    S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.
    1.9K
    Assessment of the Cardiovascular System I: Subjective Data01:23

    Assessment of the Cardiovascular System I: Subjective Data

    A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
    Initial Enquiry
    Ask the patient about their primary concern and thoroughly explore all reported symptoms.
    Medical History
    Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
    Inquire about symptoms...
    887
    Assessment of the Cardiovascular System III: Palpation01:27

    Assessment of the Cardiovascular System III: Palpation

    Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
    Jugular Venous Pressure (JVP) Measurement
    Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
    1.1K
    Intelligence01:27

    Intelligence

    The term "intelligence" is complex because it refers to both behavior and individuals, and its interpretation varies across cultures. European Americans tend to link intelligence with reasoning and cognitive skills, while in Kenya, it is tied to responsible participation in family and social life. In Uganda, intelligence is seen as the ability to know the right actions and carry them out effectively, while the Iatmul people of Papua New Guinea associate it with the capacity to remember...
    8.7K
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    5.0K